Newsletter Anmeldung

Abonnieren Sie jetzt unseren kostenlosen Newsletter! Somit entgehen Ihnen keine Nachrichten von den 4 wichtigsten Agenturen und von über 20 Börsenbriefen.

Aktuelle Börsenbriefe

• Samstag, 26. Mai 2012
  Silbernews.com:
  26.05.12 Drohender Euro-Zerfall – worauf es ankommt!
• Freitag, 25. Mai 2012
  Stock-Telegraph.com:
  ST-Blog 25.05.2012: Aurcana mit guten Zahlen
• Freitag, 25. Mai 2012
  Peter Boehringer:
  Humanismus ist etwas ganz anderes

Aktuelle Meldungen

Meldungen von

• Home
• Unternehmen
• GENMAB AS

GENMAB AS

Branche: Technologie
ISIN: DK0010272202
WKN: 565131

• Donnerstag, 24. Mai 2012 05:51
  DJ DGAP-Adhoc: Milestone Triggered in Connection with Filing of New Drug Application in Japan for Arzerra
  Genmab A S 24.05.2012 07:51 Dissemination of a Adhoc News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement.... weiter

• Freitag, 27. April 2012 06:17
  DJ DGAP-Adhoc: New Drug Application for Arzerra Submitted in Japan
  Genmab A S 27.04.2012 08:17 Dissemination of a Adhoc News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement.... weiter

• Mittwoch, 25. April 2012 11:04
  DJ DGAP-Adhoc: Arzerra First Quarter 2012 Net Sales Figures
  Genmab A S 25.04.2012 13:04 Dissemination of a Adhoc News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement.... weiter

• Montag, 26. März 2012 20:51
  DJ DGAP-Adhoc: Genmab Announces Patent Settlement Agreement for Ofatumumab
  Genmab A S 26.03.2012 22:51 Dissemination of a Adhoc News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement.... weiter

• Montag, 19. März 2012 07:03
  DJ DGAP-Adhoc: Genmab Provides Update on Ofatumumab Phase III Head to Head Study in DLBCL
  Genmab A S 19.03.2012 08:03 Dissemination of a Adhoc News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement.... weiter

• Freitag, 10. Februar 2012 07:38
  DJ DGAP-Adhoc: Genmab Reaches Second Milestone in Lundbeck Collaboration
  Genmab A S 10.02.2012 08:38 Dissemination of a Adhoc News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement.... weiter

• Dienstag, 07. Februar 2012 12:02
  DJ DGAP-Adhoc: Arzerra Fourth Quarter and Full Year 2011 Net Sales Figures
  Genmab A S 07.02.2012 13:02 Dissemination of a Adhoc News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement.... weiter

• Dienstag, 20. Dezember 2011 07:24
  DJ DGAP-Adhoc: Genmab Announces Progress with DuoBody(tm) Platform
  Genmab A S 20.12.2011 08:24 Dissemination of a Adhoc News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement.... weiter

• Donnerstag, 15. Dezember 2011 15:26
  DJ DGAP-Adhoc: Genmab Announces Progress with Lundbeck Collaboration
  Genmab A S 15.12.2011 16:26 Dissemination of a Adhoc News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement.... weiter

• Sonntag, 11. Dezember 2011 01:28
  DJ DGAP-Adhoc: Genmab Announces Preliminary Safety and Efficacy Data for Daratumumab
  Genmab A S 11.12.2011 02:28 Dissemination of a Adhoc News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement.... weiter